Disposition of 75680 shares by Gorlin Steve of Biovie at 1.69 subject to Rule 16b-3

BIVI Stock  USD 2.82  0.18  6.00%   
Under 67% of Biovie's investor base is looking to short. The analysis of the overall investor sentiment regarding Biovie Inc suggests that many traders are alarmed. Biovie's investing sentiment shows overall attitude of investors towards Biovie Inc.
  
Filed transaction by Biovie Inc Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 75680 common stock at 1.69 of Biovie by Gorlin Steve on 7th of June 2024. This event was filed by Biovie Inc with SEC on 2023-12-01. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Biovie's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Biovie's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Biovie Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Biovie can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Biovie Fundamental Analysis

We analyze Biovie's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biovie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biovie based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Biovie is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Biovie Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biovie stock to make a market-neutral strategy. Peer analysis of Biovie could also be used in its relative valuation, which is a method of valuing Biovie by comparing valuation metrics with similar companies.

Peers

Biovie Related Equities

ELDNEledon Pharmaceuticals   5.99   
0%
88.0%
XFORX4 Pharmaceuticals   2.94   
0%
43.0%
TERNTerns Pharmaceuticals   1.55   
0%
22.0%
HOOKHookipa Pharma   1.31   
0%
19.0%
DAWNDay One   0.89   
0%
13.0%
MREOMereo BioPharma   0.59   
0%
8.0%
INZYInozyme Pharma   0.38   
0%
5.0%
AMLXAmylyx Pharmaceuticals   3.71   
54.0%
0%
ABOSAcumen Pharmaceuticals   6.78   
100.0%
0%

Complementary Tools for Biovie Stock analysis

When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated